학술논문

Neratinib in patients with HER2-mutant, metastatic cervical cancer: findings from the phase 2 SUMMIT 'basket' trial.
Document Type
Article
Source
Gynecologic Oncology. Jul2019:Supplement 1, Vol. 154, p11-11. 1p.
Subject
*CERVICAL cancer
*METASTASIS
Language
ISSN
0090-8258